Brett D. Atwater, MD
Department / Division
Medicine /
Medicine - Cardiology
Address
2936 North Elm Street, Suite 102
Lumberton, NC 28358
Appointment Telephone
910-671-6619
Office Telephone
910-671-6619
Fax Telephone
910-608-0487
- MD, University of Chicago Pritzker School of Medicine (Illinois), 2002
- Internal Medicine, Duke University Medical Center, 2005
- Cardiovascular Medicine, University of Wisconsin Hospital, 2008
- Clinical Cardiac Electrophysiology, Duke University Medical Center, 2010
Clinical Interests
Clinical, procedural management of complex heart arrhythmias including atrial fibrillation, supraventricular tachycardia, ventricular tachycardia
Research Interests
Optimization of Cardiac Resynchronization Therapy, Prediction of Sudden Cardiac Death
This faculty member (or a member of their immediate family) has a working relationship (i.e. consulting, research, and/or educational services) with the companies listed below. These relations have been reported to the health system leadership and, when appropriate, management plans are in place to address potential conflicts.
- Medtronic Inc.
Representative Publications
Atwater, BD; Dai, D; Allen-Lapointe, NM; Al-Khatib, SM; Zimmer, LO; Sanders, GD; Peterson, ED. Is heart failure guideline adherence being underestimated? The impact of therapeutic contraindications. American Heart Journal. 2012;164:750-755.e1.
(2012)
Abstract
Atwater, BD; Daubert, JP. Implantable cardioverter defibrillators: risks accompany the life-saving benefits. Heart. 2012;98:764-772.
(2012)
Abstract
Atwater, BD; Wallace, TW; Kim, HW; Hranitzky, PM; Bahnson, TD; Hegland, DD; Daubert, JP. Pulmonary vein contraction before and after radiofrequency ablation for atrial fibrillation. Journal of Cardiovascular Electrophysiology. 2011;22:169-174.
(2011)
Abstract
LaPointe, NM; Al-Khatib, SM; Piccini, JP; Atwater, BD; Honeycutt, E; Thomas, K; Shah, BR; Zimmer, LO; Sanders, G; Peterson, ED. Extent of and reasons for nonuse of implantable cardioverter defibrillator devices in clinical practice among eligible patients with left ventricular systolic dysfunction. Circulation: Cardiovascular Quality and Outcomes. 2011;4:146-151.
(2011)
Abstract
Atwater, BD; Daubert, JP. Can we improve the identification of ventricular scar to guide substrate-based ventricular tachycardia ablation?. Journal of Cardiovascular Electrophysiology. 2010;21:685-687.
(2010)
Abstract
Wallace, TW; Atwater, BD; Daubert, JP; Voora, D; Crowley, AL; Bahnson, TD; Hranitzky, PM. Prevalence and clinical characteristics associated with left atrial appendage thrombus in fully anticoagulated patients undergoing catheter-directed atrial fibrillation ablation. Journal of Cardiovascular Electrophysiology. 2010;21:849-852.
(2010)
Abstract
Atwater, BD; Oujiri, J; Wolff, MR. The immediate impact of the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial on the management of stable angina. Clinical Cardiology (Hoboken): an indexed and peer-reviewed journal for advances in the treatment of cardiovascular disease. 2009;32:E1-E3.
(2009)
Abstract
Atwater, BD; Thompson, VP; Vest, RN; Shaw, LK; Mazzei, WR; Al-Khatib, SM; Hranitzky, PM; Bahnson, TD; Velazquez, EJ; Califf, RM; Lee, KL; Roe, MT. Usefulness of the Duke Sudden Cardiac Death risk score for predicting sudden cardiac death in patients with angiographic (>75% narrowing) coronary artery disease. American Journal of Cardiology. 2009;104:1624-1630.
(2009)
Abstract
Atwater, BD; Nee, LM; Gimelli, G. Long-term survival using intra-aortic balloon pump and percutaneous right ventricular assist device for biventricular mechanical support of cardiogenic shock. Journal of Invasive Cardiology. 2008;20:E205-E207.
(2008)
Abstract
